How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly

• Autores: David Y. Graham, Sun-Young Lee
• Localización: Gastroenterology clinics of North America, ISSN 0889-8553, Vol. 44, Nº. 3, 2015 (Ejemplar dedicado a: Management of Helicobacter pylori–Related Diseases), págs. 537-563
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Bismuth triple therapy was the first effective Helicobacter pylori eradication therapy. The addition of a proton pump inhibitor helped overcome metronidazole resistance. Its primary indication is penicillin allergy or when clarithromycin and metronidazole resistance are both common. Resistance to the primary first-line therapy have centered on complexity and difficulties with compliance. Understanding regional differences in effectiveness remains unexplained because of the lack of studies including susceptibility testing and adherence data. We discuss regimen variations including substitutions of doxycycline, amoxicillin, and twice a day therapy and provide suggestions regarding what is needed to rationally and effectively use bismuth quadruple therapy.